Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes

Citation
I. Zehbe et al., Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes, INT J CANC, 94(5), 2001, pp. 711-716
Citations number
30
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF CANCER
ISSN journal
00207136 → ACNP
Volume
94
Issue
5
Year of publication
2001
Pages
711 - 716
Database
ISI
SICI code
0020-7136(200112)94:5<711:HP1EPI>2.0.ZU;2-C
Abstract
Infection with high-risk human papillomavirus (HPV) is necessary for the de velopment of a cervical lesion, but only a fraction of precursor lesions pr ogress to cancer. Additional factors, other than HPV type per se, are likel y to increase the probability for progression. Intratype genome variations have been reported to be associated with viral persistence and the developm ent of a major cervical disease. We have recently shown that the prevalence of specific HPV16-E6 variants in invasive cervical cancer (ICC) varies bet ween Italian and Swedish women. To extend our initial study we have analyze d E6 variants in cervical lesions from Czech women, ranging from low-grade cervical intraepithelial neoplasia (LCIN) to ICC and scaled up the sample s ize of our initial study of Swedish and Italian women. In addition, we have correlated the cases of cancers with human leukocyte antigen (HLA) class I I haplotypes. In line with our earlier observation, the distribution of spe cific HPVI6-E6 genotypes in CIN and ICC varied in the 3 cohorts. For instan ce, the HPV16-E6 L83V variant, which has been found to be positively associ ated with ICC in Swedish women (p=0.002), was more prevalent in LCIN than i n ICC in Italian and Czech women (p=0.01 and = 0.03, respectively). These d ata indicate that host genetic factors, such as HLA polymorphism, may deter mine the potential oncogenicity of the HPVI6-E6 L83V variant. Indeed, the D R04-DQ03 haplotype, which is approximately 3-fold more abundant in the norm al Swedish population than in those in Italy and the Czech Republic, was fo und to be positively associated with HPVI6-E6 L83V in the 3 cohorts investi gated (p=0.01). This observation may explain why L83V is a risk factor more in Sweden than in the other 2 countries. (C) 2001 Wiley-Liss, Inc.